Reported about 9 hours ago
Billionaires are purchasing shares of Pfizer, a major pharmaceutical company, as its stock has recently dropped nearly 49%. Despite challenges such as impending patent expirations and increasing competition for key drugs like Eliquis and Ibrance, Pfizer continues to innovate and has strong sales in new products like Nurtec and Padcev. The company maintains a solid dividend yield of 6.4% and is expected to keep raising dividends. As the stock trades at a low valuation, many investors are considering following billionaires' lead in buying Pfizer shares amidst the company's long-term growth potential.
Source: YAHOO